Across Canada, healthcare professionals are carefully modifying their methods to BZD prescribing following the release of recent guidelines. These directives aim to reduce the risks associated with long-term use and addiction, stressing the critical need of detailed patient evaluations and considering different therapy choices. The focus is shiftin